About KolateAI: Revolutionizing Pharma with AI-Powered Insights

We are a team of tech-savvy entrepreneurs with deep pharma industry experience, dedicated to transforming drug development.

Partner with us

Vision

At KolateAI, our vision is to revolutionize drug development by seamlessly and efficiently matching the right patients to each treatment.

Mission

Provide patient-level Clinical Events Prediction and Targeting to transform pharma trials and real-world studies. A key issue is that pharma's lack visibility to future study clinical events and patient-specific impacts, driving study failure. With our AI foundation models, we predict patient-level clinical events (drug response, adverse events, study end-points). Our product enables pharma’s to target the best-suited patients, provides predictive comparison of alternative therapies, and pro-actively allows them to manage study trajectory.

What We Do

KolateAI dramatically transforms pharma clinical studies with our patient-level Clinical Events Prediction engine that enables precision medicine by targeting the best-suited patients

KolateAI Predict

Targeted tool to predict patient-level clinical outcomes

KolateAI Compare

Targeted tool that enables seamless emulated head-to-head comparison of alternative therapy options

KolateAI Co-pilot

Enable effective study management leveraging our Co-pilot for real-time queries related to our predictions, study actuals, and study documentation (protocols, patient narratives, etc.)

Founder

Vinodh Balaraman

Founder & CEO

Vinodh is a world-class healthcare exec with a proven track record of building tech-based businesses and is a repeat entrepreneur. He has worked on large life sciences consulting assignments and led multifold growth in many situations, including as a Senior Partner at ZS and SVP at Atos. Vinodh holds an MBA from Chicago Booth, MSIE from Purdue, and BSME from IIT Madras.